Literature DB >> 20672791

Global risk of coronary heart disease: assessment and application.

Anthony J Viera1, Stacey L Sheridan.   

Abstract

Coronary heart disease is the most common cause of death in the United States. The conventional risk factor approach to primary prevention excludes many patients who could benefit from preventive therapies. A global risk approach allows more accurate estimates of risk to guide clinical primary prevention efforts. Global risk of coronary heart disease is a calculation of the absolute risk of having a coronary heart disease event (e.g., death, myocardial infarction) over a specified period. It is based on an empiric equation that combines major risk factors, such as blood pressure and cholesterol levels. When physicians know a patient's global risk of coronary heart disease, they are more likely to prescribe risk-reducing therapies such as antihypertensives, statins, and aspirin. In addition, patients who know their risk level are more likely to initiate risk-reducing therapies. Many tools are available to estimate global risk, including several Web-based calculators. In the United States, tools based on the Framingham Heart Study are recommended.

Entities:  

Mesh:

Year:  2010        PMID: 20672791

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  Perioperative clopidogrel and postoperative events after hip and knee arthroplasties.

Authors:  Sumon Nandi; Mehran Aghazadeh; Carl Talmo; Claire Robbins; James Bono
Journal:  Clin Orthop Relat Res       Date:  2012-03-09       Impact factor: 4.176

2.  Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe.

Authors:  Emily P Hyle; Julia H A Foote; Fatma M Shebl; Yiqi Qian; Krishna P Reddy; Shibani S Mukerji; Nattanicha Wattananimitgul; Anand Viswanathan; Lee H Schwamm; Ankur Pandya; Kenneth A Freedberg
Journal:  BMJ Open       Date:  2022-07-06       Impact factor: 3.006

3.  Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review.

Authors:  U Ralapanawa; R Sivakanesan
Journal:  J Epidemiol Glob Health       Date:  2021-01-07

4.  Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians.

Authors:  Benjamin Shillinglaw; Anthony J Viera; Teresa Edwards; Ross Simpson; Stacey L Sheridan
Journal:  BMC Health Serv Res       Date:  2012-01-24       Impact factor: 2.655

5.  No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.

Authors:  Karen Broekhuizen; Mireille N M van Poppel; Lando L Koppes; Iris Kindt; Johannes Brug; Willem van Mechelen
Journal:  BMC Res Notes       Date:  2012-07-04

6.  Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.

Authors:  Jason F Goldberg; Kirsten K Ness; Xiaofei Chi; Aimee K Santucci; Juan Carlos Plana; Vijaya M Joshi; Russell V Luepker; Jean-Bernard Durand; Robyn E Partin; Rebecca M Howell; Carmen L Wilson; Jeffrey A Towbin; John L Jefferies; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-08       Impact factor: 4.090

7.  Financial Burden and Impoverishment Due to Cardiovascular Medications in Low and Middle Income Countries: An Illustration from India.

Authors:  Kiran Raj Pandey; David O Meltzer
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

8.  Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study.

Authors:  Chadia Haddad; Souheil Hallit; Pascale Salameh; Tarek Bou-Assi; Marouan Zoghbi
Journal:  J Comorb       Date:  2017-07-13

9.  Acute effects of outdoor air pollution on emergency department visits due to five clinical subtypes of coronary heart diseases in shanghai, china.

Authors:  Juan Xie; Mingzhen He; Weiying Zhu
Journal:  J Epidemiol       Date:  2014-07-05       Impact factor: 3.211

10.  Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?

Authors:  Sarah S Singh; Courtney S Pilkerton; Carl D Shrader; Stephanie J Frisbee
Journal:  BMC Public Health       Date:  2018-04-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.